Trial Profile
Determining the Effect in HIV positive men of Abacavir administration on markers of Platelet Activation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Abacavir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 21 May 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Jun 2013 Planned end date (Aug 2014) added as reported by ClinicalTrials.gov.
- 28 Jun 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01886638).